pharmaceutical investing Bio-Path Announces Clinical Update to Interim Analysis of Phase 2 Prexigebersen Trial in Acute Myeloid Leukemia
Tenax Therapeutics Activates First Clinical Research Site for Phase 2 Pulmonary Hypertension Clinical Trial
pharmaceutical investing Reata Pharmaceuticals Announces First Quarter 2018 Financial Results and an Update on Development Programs
pharmaceutical investing Menlo Therapeutics Announces Results from a Phase 2 Trial of Serlopitant for Pruritus Associated with Atopic Dermatitis
pharmaceutical investing Selecta Biosciences Announces Fourth Quarter and Year End 2017 Financial Results and Provides Corporate Update
IBN Announces Latest Episode of The MiningNewsWire Podcast featuring Kimberly Ann, CEO of Lahontan Gold Corp.
Skyharbour's Partner Company UraEx Resources Commences Summer 2025 Drilling Program at South Dufferin Uranium Project, Athabasca Basin, Saskatchewan
Sranan Gold Announces Investor Webinar on Exploration Activities at the Tapanahony Project in Suriname